|Day Low/High||52.20 / 53.45|
|52 Wk Low/High||43.62 / 57.05|
Fed Chair Jerome Powell appears intent to reverse a near decade's worth of policy in just a couple of years.
Underwater positions on stocks you feel lukewarm about are prime candidates for tax selling.
Our index of 30 cutting-edge companies fell ... but not as much as the Nasdaq did.
Focus on facts when evaluating WBA's latest quarterly results.
The big, bad wolf showed up at the door on Wednesday, but here are ways to deal with him.
CNBC is reporting that Kroger and Walgreens Boots Alliance are "exploring a partnership to offer customers a new service that allows them to pick up groceries ordered online at Kroger at certain Walgreens locations..." Yes this signals that more ch...
Straying from these names could land you in quicksand as the 4th quarter begins.
We forgot that this nation is a nation based on consumption, not on industry, on sales, not on making things.
Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.
Rite Aid CEO John Standley faces shareholders's scrutiny after the merger flop.
After a failed merger with Albertsons, Rite Aid faces a difficult time on its own in a changing landscape.
A week of bad news for Ride Aid may be good news for its competitors Walgreens and CVS.
Prime Day 2018 is expected to generate $3.4 billion in sales, according to Coresight Research.
Here's to FANG for once again exciting and enthralling and defying all of the negatives.
Shares were down 8% Thursday.
Amazon's acquisition of PillPack is hitting traditional pharmacies.
These stocks are selling at historically low earnings multiples, but have raised their dividends for decades.
Stocks traded in a different pattern Wednesday, as big tech names dominated.
I know there's plenty of irony to go around for this once great manufacturer to be replaced in the Dow by a drug store chain.
Drugstore giant's charts were showing positive signs even before its inclusion in the Dow Jones Industrial Average.
GE is getting tossed from the index, after 111 consecutive years.
These are the stories pushing futures higher ahead of Wednesday's opening bell.
The drugstore chain's price to fair value has not been this favorable since the Crash of 2008-2009.
Theranos, once a Silicon Valley unicorn promising investors and partners like Walgreens a simple blood-testing solution, is a cautionary tale for biotech investors.
Few companies can match CVS' long-term record and top-quality corporate metrics.